BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 15918000)

  • 1. Enhancement of DNA vaccine potency through linkage of antigen gene to ER chaperone molecules, ER-60, tapasin, and calnexin.
    Lin CT; Chang TC; Chao A; Dzeng E; Soong YK; Hung CF; Lai CH
    J Biomed Sci; 2005; 12(2):279-87. PubMed ID: 15918000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-specific immunity and antiangiogenesis generated by a DNA vaccine encoding calreticulin linked to a tumor antigen.
    Cheng WF; Hung CF; Chai CY; Hsu KF; He L; Ling M; Wu TC
    J Clin Invest; 2001 Sep; 108(5):669-78. PubMed ID: 11544272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of HPV DNA vaccines employing intracellular targeting strategies.
    Kim JW; Hung CF; Juang J; He L; Kim TW; Armstrong DK; Pai SI; Chen PJ; Lin CT; Boyd DA; Wu TC
    Gene Ther; 2004 Jun; 11(12):1011-8. PubMed ID: 14985791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of vaccinia vaccine potency by linkage of tumor antigen gene to gene encoding calreticulin.
    Hsieh CJ; Kim TW; Hung CF; Juang J; Moniz M; Boyd DA; He L; Chen PJ; Chen CH; Wu TC
    Vaccine; 2004 Sep; 22(29-30):3993-4001. PubMed ID: 15364449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Noncarrier naked antigen-specific DNA vaccine generates potent antigen-specific immunologic responses and antitumor effects.
    Chen CA; Chang MC; Sun WZ; Chen YL; Chiang YC; Hsieh CY; Chen SM; Hsiao PN; Cheng WF
    Gene Ther; 2009 Jun; 16(6):776-87. PubMed ID: 19357714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of HPV-16 E6 DNA vaccines employing intracellular targeting and intercellular spreading strategies.
    Peng S; Trimble C; Ji H; He L; Tsai YC; Macaes B; Hung CF; Wu TC
    J Biomed Sci; 2005 Oct; 12(5):689-700. PubMed ID: 16200349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant DNA vaccines protect against tumors that are resistant to recombinant vaccinia vaccines containing the same gene.
    Chen CH; Wang TL; Ji H; Hung CF; Pardoll DM; Cheng WF; Ling M; Wu TC
    Gene Ther; 2001 Jan; 8(2):128-38. PubMed ID: 11313782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sindbis virus replicon particles encoding calreticulin linked to a tumor antigen generate long-term tumor-specific immunity.
    Cheng WF; Lee CN; Su YN; Chai CY; Chang MC; Polo JM; Hung CF; Wu TC; Hsieh CY; Chen CA
    Cancer Gene Ther; 2006 Sep; 13(9):873-85. PubMed ID: 16645621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA vaccine encoding heat shock protein 60 co-linked to HPV16 E6 and E7 tumor antigens generates more potent immunotherapeutic effects than respective E6 or E7 tumor antigens.
    Huang CY; Chen CA; Lee CN; Chang MC; Su YN; Lin YC; Hsieh CY; Cheng WF
    Gynecol Oncol; 2007 Dec; 107(3):404-12. PubMed ID: 17905417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of DNA vaccine potency by linkage of antigen gene to an HSP70 gene.
    Chen CH; Wang TL; Hung CF; Yang Y; Young RA; Pardoll DM; Wu TC
    Cancer Res; 2000 Feb; 60(4):1035-42. PubMed ID: 10706121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimal induction of HPV DNA vaccine-induced CD8+ T cell responses and therapeutic antitumor effect by antigen engineering and electroporation.
    Seo SH; Jin HT; Park SH; Youn JI; Sung YC
    Vaccine; 2009 Sep; 27(42):5906-12. PubMed ID: 19651174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of suicidal DNA vaccine potency by linking Mycobacterium tuberculosis heat shock protein 70 to an antigen.
    Hsu KF; Hung CF; Cheng WF; He L; Slater LA; Ling M; Wu TC
    Gene Ther; 2001 Mar; 8(5):376-83. PubMed ID: 11313814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene gun-mediated DNA vaccination induces antitumor immunity against human papillomavirus type 16 E7-expressing murine tumor metastases in the liver and lungs.
    Chen CH; Ji H; Suh KW; Choti MA; Pardoll DM; Wu TC
    Gene Ther; 1999 Dec; 6(12):1972-81. PubMed ID: 10637448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antigen-specific CD8+ T lymphocytes generated from a DNA vaccine control tumors through the Fas-FasL pathway.
    Cheng WF; Lee CN; Chang MC; Su YN; Chen CA; Hsieh CY
    Mol Ther; 2005 Nov; 12(5):960-8. PubMed ID: 15979942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel therapeutic fusion protein vaccine by two different families of heat shock proteins linked with HPV16 E7 generates potent antitumor immunity and antiangiogenesis.
    Liu B; Ye D; Song X; Zhao X; Yi L; Song J; Zhang Z; Zhao Q
    Vaccine; 2008 Mar; 26(10):1387-96. PubMed ID: 18272260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement of suicidal DNA vaccine potency by delaying suicidal DNA-induced cell death.
    Kim TW; Hung CF; Juang J; He L; Hardwick JM; Wu TC
    Gene Ther; 2004 Feb; 11(3):336-42. PubMed ID: 14737094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A DNA vaccine encoding a codon-optimized human papillomavirus type 16 E6 gene enhances CTL response and anti-tumor activity.
    Lin CT; Tsai YC; He L; Calizo R; Chou HH; Chang TC; Soong YK; Hung CF; Lai CH
    J Biomed Sci; 2006 Jul; 13(4):481-8. PubMed ID: 16649071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccination with a DNA vaccine based on human PSCA and HSP70 adjuvant enhances the antigen-specific CD8+ T-cell response and inhibits the PSCA+ tumors growth in mice.
    Zhang X; Yu C; Zhao J; Fu L; Yi S; Liu S; Yu T; Chen W
    J Gene Med; 2007 Aug; 9(8):715-26. PubMed ID: 17595048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombined DNA vaccines encoding calreticulin linked to HPV6bE7 enhance immune response and inhibit angiogenic activity in B16 melanoma mouse model expressing HPV 6bE7 antigen.
    Zhao KJ; Cheng H; Zhu KJ; Xu Y; Chen ML; Zhang X; Song T; Ye J; Wang Q; Chen DF
    Arch Dermatol Res; 2006 Jul; 298(2):64-72. PubMed ID: 16710741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of dendritic cell-based vaccine potency by targeting antigen to endosomal/lysosomal compartments.
    Kang TH; Lee JH; Bae HC; Noh KH; Kim JH; Song CK; Shin BC; Hung CF; Wu TC; Park JS; Kim TW
    Immunol Lett; 2006 Aug; 106(2):126-34. PubMed ID: 16844231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.